Market Cap | ₹2,593Cr |
ROE | 10.81% |
P/E Ratio(TTM) | 35.45 |
EPS(TTM) | 8.25 |
P/B Ratio | 4.05 |
Dividend Yield | 0.14% |
Industry P/E | 35.77 |
Book Value | 72.15 |
Debt to Equity | 0.49 |
Face Value | 1 |
Parent Organisation | Sms Pharmaceuticals |
Managing Director | Shri. Ramesh Potluri |
NSE Symbol | SMSPHARMA |
FUND NAME | AUM(%) |
---|---|
Quant Small Cap Fund Direct Plan Growth | 0.15% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 71.36 | ||
Neuland Laboratories | NA (0.00%) | 112.37 | ||
Jubilant Pharmova | NA (0.00%) | 38.19 | ||
Acutaas Chemicals | NA (0.00%) | 62.65 |